Protein Degradation (eBook)
XVI, 242 Seiten
Wiley-VCH (Verlag)
978-3-527-62030-2 (ISBN)
The editors and authors represent unmatched expertise, comprising virtually all the top scientists in the field, including the pioneers of protein degradation research.
From the contents:
* Ubiquitin and cancer
* Ubiquitin and liver cancer
* Muscle atrophy
* Aggresomes and human disease
* Parkin and neurodegeneration
* Chronic neurodegenerative diseases
* Parkinson's disease
* Ubiquitin and viruses
* Druggability of the ubiquitin-proteasome system
Required reading for molecular and cell biologists, as well as physiologists with an interest in the topic.
John Mayer obtained his MS and PhD degrees from the University of Birmingham (UK). He is currently serving as Professor of Biochemistry at the School of Biomedical Sciences at Nottingham University. For the past 30 years, he has investigated intracellular proteolysis and particularly the ubiquitin/proteasome system. Presently, he is particularly interested in intracellular proteolysis in relation to neurodegenerative illnesses. Aaron Ciechanover obtained his MD from the Hebrew University in Jerusalem (Israel), and his PhD from the Technion-Israel Institute of Technology in Haifa, where he is presently serving as Professor of Biochemistry. Professor Ciechanover is known for his discovery of the first ubiquitin system mutant cell, demonstrating the role of the ubiquitin-proteasome proteolytic system in protein degradation in vivo. In 2004, he has received the Nobel Prize in Chemistry for his ground-breaking work on the ubiquitin-proteasome system. Martin Rechsteiner is Professor of Biochemistry at the University of Utah in Salt Lake City (USA). He is interested in the proteasome component of the ubiquitin-proteasome pathway. He has identified several key regulators of proteasome function and is currently working on their structural and functional elucidation.
Ubiquitin signaling and cancer pathogenesis
Regulation of the p53 tumor-suppressor protein by ubiquitin and ubiquitin-like molecules
The ubiquitin-proteasome system in Epstein-Barr virus infection and oncogenesis
HECT ubiquitin-protein ligases in human disease
Ubiquitin-independent mechanisms of substrate recognition and degradation by the proteasome
Endoplasmic reticulum protein quality control and degradation
Interactions between viruses and the ubiquitin-proteasome system
The ubiquitin-proteasome system in Parkinson's disease
The molecular pathway to neurodegeneration in parkin-related Parkinsonism
Parkin and neurodegeneration
Erscheint lt. Verlag | 25.6.2008 |
---|---|
Reihe/Serie | Protein Degradation ; 4 |
Sprache | englisch |
Themenwelt | Naturwissenschaften ► Biologie |
Naturwissenschaften ► Chemie ► Organische Chemie | |
Technik | |
Schlagworte | Biochemie • Biowissenschaften • Chemie • Chemistry • Life Sciences • Molecular Biology • Molekularbiologie • Proteine • Protein Science |
ISBN-10 | 3-527-62030-3 / 3527620303 |
ISBN-13 | 978-3-527-62030-2 / 9783527620302 |
Haben Sie eine Frage zum Produkt? |
Größe: 2,9 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich